TY - JOUR
T1 - Transcription factor AP2alpha (TFAP2a) regulates differentiation and proliferation of neuroblastoma cells
AU - Schulte, Johannes H.
AU - Kirfel, Jutta
AU - Lim, Soyoung
AU - Schramm, Alexander
AU - Friedrichs, Nicolaus
AU - Deubzer, Hedwig E.
AU - Witt, Olaf
AU - Eggert, Angelika
AU - Buettner, Reinhard
N1 - Funding Information:
We thank Francoise Halley, Theresia Walter and Birte Sönnichsen (Cenix BioScience GmbH, Dresden, Germany) for performing the siRNA experiments; Sabine Dreesmann for excellent technical assistance; Kathy Astrahantseff for critical reading of the manuscript as well as Barbara Hero and the German Neuroblastoma Study Group for providing clinical data. A.E., O.W. and A.S. were supported by grants from the National Genome Research Network (NGFN), R.B. was supported by a grant from the DFG.
Copyright:
Copyright 2009 Elsevier B.V., All rights reserved.
PY - 2008/11/18
Y1 - 2008/11/18
N2 - Neuroblastoma, the most common extracranial solid tumour of childhood, is derived from neural crest progenitor cells. The TFAP2a transcription factor regulates neural crest patterning. We analysed TFAP2a protein expression in 97 primary neuroblastic tumors and report that TFAP2a was strongly expressed in poorly differentiated neuroblastomas. TFAP2a expression in tumor cells of differentiated neuroblastic tumors was below detection. TFAP2a was strongly expressed in 4 of 6 neuroblastoma cell lines tested, and TFAP2a siRNA mediated knock down in SH-EP cells reduced proliferation and induced a more differentiated phenotype associated with an increase in the expression of the differentiation marker neurotensin.
AB - Neuroblastoma, the most common extracranial solid tumour of childhood, is derived from neural crest progenitor cells. The TFAP2a transcription factor regulates neural crest patterning. We analysed TFAP2a protein expression in 97 primary neuroblastic tumors and report that TFAP2a was strongly expressed in poorly differentiated neuroblastomas. TFAP2a expression in tumor cells of differentiated neuroblastic tumors was below detection. TFAP2a was strongly expressed in 4 of 6 neuroblastoma cell lines tested, and TFAP2a siRNA mediated knock down in SH-EP cells reduced proliferation and induced a more differentiated phenotype associated with an increase in the expression of the differentiation marker neurotensin.
UR - http://www.scopus.com/inward/record.url?scp=53249087909&partnerID=8YFLogxK
U2 - 10.1016/j.canlet.2008.05.039
DO - 10.1016/j.canlet.2008.05.039
M3 - Journal articles
C2 - 18620802
AN - SCOPUS:53249087909
SN - 0304-3835
VL - 271
SP - 56
EP - 63
JO - Cancer Letters
JF - Cancer Letters
IS - 1
ER -
